Valuation: Solara Active Pharma Sciences Limited

Market Cap 30.57B 325M 292M 267M 243M 459M 473M 3.21B 1.28B 16.31B 1.22B 1.19B 51.5B P/E 2025
3,792x
P/E 2026 -253x
Enterprise Value 37.37B 397M 357M 326M 297M 560M 578M 3.93B 1.57B 19.94B 1.49B 1.46B 62.94B EV / Sales 2025
2.54x
EV / Sales 2026 1.99x
Free-Float
47.77%
Yield 2025 *
-
Yield 2026 -
1 day-1.49%
1 week-3.29%
Current month+0.17%
1 month-6.38%
3 months+23.13%
6 months+26.44%
Current year+12.17%
1 week 618.7
Extreme 618.7
657.55
1 month 525.15
Extreme 525.15
759
Current year 422
Extreme 422
774
1 year 422
Extreme 422
774
3 years 317.55
Extreme 317.55
882.8
5 years 286
Extreme 286
1,384
10 years 134.5
Extreme 134.5
1,859.95
Manager TitleAgeSince
Chief Executive Officer - 2025-02-20
Director of Finance/CFO - 2025-02-20
Chief Tech/Sci/R&D Officer 74 2026-08-09
Director TitleAgeSince
Chairman 73 2018-04-10
Director/Board Member 58 2018-04-10
Director/Board Member 75 2023-11-13
Date Insider Type Main position Quantity % Market Cap. Importance
3/14/25 Buy

Director

1,000 0.0021%
3/6/25
Pronomz Ventures LLP
BuyCompany 13,600 0.0283%
3/4/25
Pronomz Ventures LLP
BuyCompany 216,361 0.4503%
Change 5-day change 1-year change 3-year change Capi.($)
-1.49%-3.29%+2.68%+85.48% 328M
-0.79%-1.43%+46.25%+138.46% 1,216B
+1.43%+0.37%+48.51%+82.52% 656B
+1.07%+0.18%+34.39%+105.99% 509B
-0.36%-2.84%+47.23%+64.51% 384B
-0.14%+0.27%+73.87%+41.93% 362B
-0.78%+0.59%+31.01%+59.68% 311B
-0.80%+6.73%+11.89%+35.64% 293B
+0.03%-0.07%+43.94%+70.61% 249B
-0.41%+0.77%+36.15%+104.55% 208B
Average +0.04%+0.36%+37.59%+78.94% 418.81B
Weighted average by Cap. +0.70%+0.03%+43.46%+91.86%

Financials

2025 2026
Net sales 12.84B 137M 122M 112M 102M 193M 199M 1.35B 538M 6.85B 513M 502M 21.62B 13.69B 146M 131M 119M 109M 205M 212M 1.44B 574M 7.3B 547M 535M 23.06B
Net income 5.4M 57.45K 51.52K 47.09K 42.98K 80.98K 83.54K 568K 226K 2.88M 216K 211K 9.1M -74.1M -788K -707K -646K -590K -1.11M -1.15M -7.79M -3.11M -39.54M -2.96M -2.9M -125M
Net Debt 7.92B 84.27M 75.58M 69.07M 63.05M 119M 123M 833M 332M 4.23B 316M 310M 13.34B 6.79B 72.24M 64.79M 59.22M 54.05M 102M 105M 714M 285M 3.62B 271M 265M 11.44B
Projected Income Statement - Annual - Solara Active Pharma Sciences Limited
Logo Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is an India-based global, pureplay active pharmaceutical ingredients (API) company. The Company is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. It has one R&D center in Chennai.
Employees
1,669
Date Price Change Volume
26-11-06 ₹633.70 -1.49% 173,359
26-11-05 ₹643.30 -0.25% 109,840
26-11-04 ₹644.90 +2.41% 107,612
26-11-03 ₹629.75 -1.32% 108,394
26-11-02 ₹638.15 +0.88% 135,253

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Solara Active Pharma Sciences Limited
  1. Stock Market
  2. Stocks
  3. SOLARA Stock